XBiotech Inc. - Common Shares, no par value (XBIT)

49 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q1 2024.
XBiotech Inc. - Common Shares, no par value (XBIT) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,994,151 shares of 33,289,095 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include MILLENNIUM MANAGEMENT LLC (927,368 shares), VANGUARD GROUP INC (895,315 shares), BlackRock Inc. (306,624 shares), CREDIT SUISSE AG/ (248,270 shares), GEODE CAPITAL MANAGEMENT, LLC (195,204 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (169,812 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (149,318 shares), MORGAN STANLEY (116,327 shares), Connor, Clark & Lunn Investment Management Ltd. (77,413 shares), and NORTHERN TRUST CORP (75,389 shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.